KI-Beratung Beta

Produktbild: The Wilms' Tumor (WT1) Gene
Band 1467 - 12%

The Wilms' Tumor (WT1) Gene Methods and Protocols

12% sparen

95,99 € UVP 109,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

This volume provides a thorough overview of the Wilms’ Tumour Gene (WT1). The book begins with three review chapters that cover the involvement of WT1 in pediatric cancer, kidney disease, and tissue development and homeostasis. The next few chapters discuss cell marking and lineage tracing, epicardial...

Beschreibung

This volume provides a thorough overview of the Wilms’ Tumour Gene (WT1). The book begins with three review chapters that cover the involvement of WT1 in pediatric cancer, kidney disease, and tissue development and homeostasis. The next few chapters discuss cell marking and lineage tracing, epicardial cell methodology, colony forming assays for bone marrow stem cells, angiogenesis assays and zebrafish tools.  The next group of chapters explores the latest tools in genomics, molecular biology, and biochemistry. They discuss dissecting transcription factor function in cell free systems, ChiP seq, proteomics, RNA interactome, and multiphoton imaging of lipids, measuring the binding constants of protein-nucleic acid interactions, and bioinformatics approaches for analyzing Next Generation Sequence data. The final chapter discusses protocols for clinical trials for immune therapy using anti-WT1 peptides. Written in the highly successful
Methods in Molecular Biology
series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Practical and thorough,
The Wilms’ Tumour (WT1) Gene: Methods and Protocols
is a valuable resource for anyone who is interested in the diverse methodologies used in WT1 research.


 

Rezension


Portrait


Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

20.07.2016

Abbildungen

X, 235 p. 42 illus., 34 illus. in color.

Herausgeber Nicholas Hastie

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

20.07.2016

Abbildungen

X, 235 p. 42 illus., 34 illus. in color.

Herausgeber Nicholas Hastie
Verlag Springer Us
Seitenzahl

235

Maße (L/B/H)

26/18,3/2 cm

Gewicht

606 g

Auflage

1st ed. 2016

Sprache

Englisch

ISBN

978-1-4939-4021-9

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: The Wilms' Tumor (WT1) Gene

  • WT1 Mutation in Childhood Cancer.- WT1 and Renal Disease.- The Role of WT1 in Embryonic Development and Normal Organ Homeostasis.- Tools and Techniques for WT1-Based Lineage Tracing.- Biological Systems and Methods for Studying WT1 in the Epicardium.- Isolation and Colony Formation of Murine Bone and Bone Marrow Cells.- Isolation and Fluorescent Activated Cell Sorting of Murine WT1-Expressing Adipocyte Precursor  Cells.- 
    In Vivo
    Assays for Assessing the Role of the Wilms’ Tumor Suppressor 1 (WT1) in Angiogenesis.- Multiphoton Microscopy for Visualizing Lipids in Tissue.- Function and Regulation of the Wilm’s Tumor Suppressor 1 (WT1) Gene in Fish.- Immunofluorescence Staining of WT1 on Sections of Zebrafish Embryos and Larvae.- Fluorescence Activated Cell Sorting (FACS) Protocol for Podocyte Isolation in Adult Zebrafish.- In Vitro Transcription to Study WT1 Function.- Measuring Equilibrium Binding Constants for the WT1-DNAInteraction Using a Filter Binding Assay.- Identifying Direct Downstream Targets: WT1 ChIP-Seq Analysis.- WT1 Associated Protein-Protein Interaction Networks.- Methods to Identify and Validate WT1-RNA Interaction.- Bioinformatic Analysis of Next Generation Sequencing Data to Identify WT1 Associated Differential Gene and Isoform Expression.- Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.